[1]
“Recurrence of dermatophytosis and therapeutic efficacy of systemic antifungals in recurrent dermatophytosis of adults– A randomized, assessor-blind controlled trial in a tertiary institution : Use of systemic antifungals in recurrent dermatophytosis: A randomized, controlled trial”., J Pak Assoc Dermatol, vol. 33, no. 4, pp. 1485–1494, Oct. 2023, doi: 10.66344/jpad.33.4.2023.2305.